Myles David C. 4
4 · Olema Pharmaceuticals, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
Transactions
- Award
Stock Option (Right to Buy)
2025-02-28+205,000→ 205,000 totalExercise: $4.37Exp: 2035-02-27→ Common Stock (205,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.